RQx lands funding through hard work and luck

11/29/2012 | Xconomy

RQx Pharmaceuticals was born after researcher Floyd Romesberg and investor Court Turner happened to strike up a conversation in a local coffee shop. Romesberg is developing arylomycin to work against gram-negative and -positive bacteria, potentially leading to a new broad-spectrum antibiotic. Turner's company, Avalon Ventures, provided the first $1 million for Romesberg to start a new company, and Correlation Ventures has since joined as a venture investor.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA